Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to widespread use of hydroxychloroquine and azithromycin despite the lack of conclusive evidence for their safety and efficacy. We evaluated the association between treatment with hydroxychloroquine and/or azithromycin...

Descripción completa

Detalles Bibliográficos
Autores principales: Albani, Filippo, Fusina, Federica, Giovannini, Alessia, Ferretti, Pierluigi, Granato, Anna, Prezioso, Chiara, Divizia, Danilo, Sabaini, Alessandra, Marri, Marco, Malpetti, Elena, Natalini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563535/
https://www.ncbi.nlm.nih.gov/pubmed/32872629
http://dx.doi.org/10.3390/jcm9092800

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563535/
https://www.ncbi.nlm.nih.gov/pubmed/32872629
http://dx.doi.org/10.3390/jcm9092800

Ejemplares similares